Medicare Enrolled
Dr. Dean Le, M.D.
Neurology · Laguna Hills, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Le from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Le?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Le
Dr. Dean Le is a neurology specialist in Laguna Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Le performed 41,746 Medicare services across 1,393 unique beneficiaries.
Between the years covered by Open Payments, Dr. Le received a total of $18,113 from 87 pharmaceutical and/or device companies across 774 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Le is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in CA
$18,113 industry payments
Medicare Practice Summary
Medicare Utilization ↗41,746
Medicare services
Top 2% in CA for neurology
1,393
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,197 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
39,300 | $5 | $12 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
897 | $145 | $244 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
577 | $105 | $205 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
334 | $88 | $113 |
| New patient office visit, complex (60-74 min) | 175 | $171 | $314 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
117 | $129 | $167 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
81 | $156 | $200 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
55 | $344 | $453 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
52 | $253 | $322 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
46 | $59 | $150 |
| Chemical nerve block injection, 1-4 muscles An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated. |
38 | $131 | $171 |
| Chemical nerve block injection, 5+ arm/leg muscles Injection of a chemical agent to paralyze five or more muscles in the first extremity treated. |
36 | $154 | $350 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 27 | $80 | $104 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $121 | $276 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,113
Total received (2018-2024)
Avg $2,588/year across 7 years
Top 16% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
87
Companies
774
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,077 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$36 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,440
2023
$4,611
2022
$3,133
2021
$1,110
2020
$528
2019
$2,325
2018
$1,966
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$714
ABBVIE INC.
$560
Alexion Pharmaceuticals, Inc.
$331
Lilly USA, LLC
$253
Lundbeck LLC
$208
Neurocrine Biosciences, Inc.
$197
Teva Pharmaceuticals USA, Inc.
$163
Eisai Inc.
$156
SK Life Science, Inc.
$148
Amgen Inc.
$139
ARGENX US, INC.
$133
EMD Serono, Inc.
$122
PFIZER INC.
$120
Biogen, Inc.
$118
ANI Pharmaceuticals, Inc.
$91
Ipsen Biopharmaceuticals, Inc
$85
Boston Scientific Corporation
$69
HARMONY BIOSCIENCES LLC
$68
Takeda Pharmaceuticals U.S.A., Inc.
$66
LivaNova USA, Inc.
$65
Otsuka America Pharmaceutical, Inc.
$64
Grifols USA, LLC
$59
Averitas Pharma Inc.
$54
Novartis Pharmaceuticals Corporation
$52
SCILEX PHARMACEUTICALS INC.
$51
Alnylam Pharmaceuticals Inc.
$49
MDD US Operations, LLC
$48
GE HEALTHCARE
$43
Amneal Pharmaceuticals LLC
$39
Octapharma USA, Inc.
$36
Abbott Laboratories
$29
CSL Behring
$24
REVANCE THERAPEUTICS, INC.
$19
Kyowa Kirin, Inc.
$18
Vanda Pharmaceuticals Inc.
$17
Merz Pharmaceuticals, LLC
$17
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
Top 3 companies account for 36.2% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,654
UCB, Inc.
$1,458
Alexion Pharmaceuticals, Inc.
$932
Biogen, Inc.
$912
EMD Serono, Inc.
$888
Neurocrine Biosciences, Inc.
$876
Lilly USA, LLC
$681
Medtronic USA, Inc.
$585
SK Life Science, Inc.
$580
Novartis Pharmaceuticals Corporation
$560
Lundbeck LLC
$552
Teva Pharmaceuticals USA, Inc.
$503
Amgen Inc.
$438
Eisai Inc.
$398
Abbott Laboratories
$369
ANI Pharmaceuticals, Inc.
$277
Sunovion Pharmaceuticals Inc.
$273
PFIZER INC.
$270
ARGENX US, INC.
$265
Amneal Pharmaceuticals LLC
$262
Takeda Pharmaceuticals U.S.A., Inc.
$256
Celgene Corporation
$251
Grifols USA, LLC
$241
Allergan Inc.
$232
Genentech USA, Inc.
$224
CSL Behring
$198
Harmony Biosciences LLC
$184
Octapharma USA, Inc.
$177
IMPEL PHARMACEUTICALS INC.
$165
Adamas Pharmaceuticals, Inc.
$164
AbbVie Inc.
$148
AstraZeneca Pharmaceuticals LP
$144
GENZYME CORPORATION
$140
Biohaven Pharmaceutical Holding Company Ltd.
$128
Horizon Therapeutics plc
$125
Boston Scientific Corporation
$123
Otsuka America Pharmaceutical, Inc.
$123
Merz Pharmaceuticals, LLC
$121
ACADIA Pharmaceuticals Inc
$121
Avion Pharmaceuticals
$118
Allergan, Inc.
$115
MDD US Operations, LLC
$103
LivaNova USA, Inc.
$97
GE HEALTHCARE
$89
Corium, LLC
$86
Ipsen Biopharmaceuticals, Inc
$85
Averitas Pharma Inc.
$77
EISAI INC.
$76
MITSUBISHI TANABE PHARMA AMERICA, INC.
$75
Alnylam Pharmaceuticals Inc.
$71
HARMONY BIOSCIENCES LLC
$68
Medtronic, Inc.
$52
SCILEX PHARMACEUTICALS INC.
$51
Supernus Pharmaceuticals, Inc.
$51
Upsher-Smith Laboratories LLC
$49
Avanir Pharmaceuticals, Inc.
$47
Impax Laboratories, Inc.
$46
GE Healthcare
$46
Strongbridge US INC.
$45
NEUROPACE, INC.
$45
Kyowa Kirin, Inc.
$42
Biohaven Pharmaceuticals, Inc.
$38
Acorda Therapeutics, Inc
$36
Xeris Pharmaceuticals, Inc.
$35
Alfasigma USA, Inc.
$32
ASSERTIO THERAPEUTICS, Inc.
$32
ARBOR PHARMACEUTICALS, INC.
$30
GE HealthCare
$28
Mallinckrodt Hospital Products Inc.
$27
Mallinckrodt Enterprises LLC
$26
ABB Con-Cise Optical Group LLC
$25
UPSHER-SMITH LABORATORIES LLC
$24
Vertical Pharmaceuticals, LLC
$23
CATALYST PHARMACEUTICALS, INC.
$23
Mitsubishi Tanabe Pharma America, Inc.
$22
REVANCE THERAPEUTICS, INC.
$19
BIOTRONIK INC.
$18
BOSTON SCIENTIFIC CORPORATION
$17
Vanda Pharmaceuticals Inc.
$17
Arbor Pharmaceuticals, Inc.
$17
Janssen Pharmaceuticals, Inc
$17
Cranial Technologies, Inc
$15
Bausch Health US, LLC
$14
Assertio Therapeutics, Inc.
$14
Egalet US Inc
$13
Bayer HealthCare Pharmaceuticals Inc.
$12
Dynasplint Systems Inc.
$6
Top 3 companies account for 22.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aduhelm · Aimovig · Austedo XR · BIOMONITOR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · COPAXONE · Cambia · Contact Lens · DAXXIFY · DIVIGEL · Dhivy · Doc Band · Dynasplint · Dysport · EMGALITY · ETERNA · Edarbi · FIRDAPSE · FORTEO · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GVOKE PFS · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INTELLIS · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Ocrevus · Ongentys · Ozanimod · PANZYGA · PAXLOVID · PONVORY · PURIFIED CORTROPHIN GEL · QALSODY · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · REXULTI · RNS Neurostimulator Kit · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · XARELTO · XCOPRI · Xeomin · ZAVZPRET · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
179
Per 100K population
5.7
County median income
$113,702
Nearest hospital
MEMORIALCARE SADDLEBACK MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Le is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Le experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Le performed 39,300 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Le receive payments from pharmaceutical companies?
Yes. Dr. Le received a total of $18,113 from 87 companies across 774 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Le's costs compare to other neurologists in Laguna Hills?
Dr. Le's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Le) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Laguna Hills
Browse neurologists in Laguna Hills ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology